生物活性 | |||
---|---|---|---|
描述 | RLX-33, a potent, selective, and blood-brain barrier (BBB) permeable antagonist of relaxin family peptide 3 (RXFP3), also inhibits relaxin-3-induced ERK1/2 phosphorylation, with IC50 values of 2.36 μM for RXFP3, and 7.82 and 13.86 μM for ERK1 and ERK2 phosphorylation, respectively. It effectively blocks the increase in feeding induced by the RXFP3-selective agonist R3/I5 in rats, making it suitable for metabolic syndrome research[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.16mL 0.43mL 0.22mL |
10.80mL 2.16mL 1.08mL |
21.60mL 4.32mL 2.16mL |
参考文献 |
---|